• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类T细胞抗原受体β链恒定区和可变区基因的复杂性

Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes.

作者信息

Sims J E, Tunnacliffe A, Smith W J, Rabbitts T H

出版信息

Nature. 1984;312(5994):541-5. doi: 10.1038/312541a0.

DOI:10.1038/312541a0
PMID:6334238
Abstract

Immune systems of vertebrates function via two types of effector cells, B and T cells, which are capable of antigen-specific recognition. The immunoglobulins, which serve as antigen receptors on B cells, have been well characterized with respect to gene structure, unlike the T-cell receptors. Recently, cDNA clones thought to correspond to the beta-chain locus of the human and mouse T-cell receptor have been described. The presumptive beta-chain clones detect gene rearrangement specifically in T-cell DNA and show homology with immunoglobulin light chains. The similarity of the T-cell beta-chain gene system to the immunoglobulin genes has been further demonstrated by the recent observation of variable- and constant-region gene segments as well as joining segments and putative diversity segments. We report here the characterization of cDNA and genomic clones encoding human T-cell receptor beta-chain genes. There are two constant-region genes (C beta 1 and C beta 2), each capable of rearrangement and expression as RNA. The gene arrangement, analogous to that of mouse beta-chain genes, shows strong evolutionary conservation of the dual C beta gene system in these two species.

摘要

脊椎动物的免疫系统通过两种效应细胞(B细胞和T细胞)发挥作用,这两种细胞能够进行抗原特异性识别。免疫球蛋白作为B细胞上的抗原受体,其基因结构已得到充分表征,这与T细胞受体不同。最近,已描述了被认为对应于人及小鼠T细胞受体β链基因座的cDNA克隆。推测的β链克隆能特异性检测T细胞DNA中的基因重排,并与免疫球蛋白轻链显示出同源性。最近对可变区和恒定区基因片段以及连接片段和假定的多样性片段的观察,进一步证明了T细胞β链基因系统与免疫球蛋白基因的相似性。我们在此报告编码人T细胞受体β链基因的cDNA和基因组克隆的表征。有两个恒定区基因(Cβ1和Cβ2),每个基因都能够重排并作为RNA表达。这种基因排列类似于小鼠β链基因,显示出这两个物种中双Cβ基因系统在进化上的强烈保守性。

相似文献

1
Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes.人类T细胞抗原受体β链恒定区和可变区基因的复杂性
Nature. 1984;312(5994):541-5. doi: 10.1038/312541a0.
2
Identification of a diversity segment of human T-cell receptor beta-chain, and comparison with the analogous murine element.人T细胞受体β链多样性区段的鉴定及其与类似小鼠元件的比较。
Nature. 1984;311(5984):387-9. doi: 10.1038/311387a0.
3
Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.对来自人T细胞系的人T细胞特异性cDNA克隆以及T细胞受体异二聚体的α和β链的分析。
Proc Natl Acad Sci U S A. 1985 May;82(10):3430-4. doi: 10.1073/pnas.82.10.3430.
4
Primary structure of human T-cell receptor alpha-chain.人T细胞受体α链的一级结构
Nature. 1984;312(5996):771-5. doi: 10.1038/312771a0.
5
Organization and sequences of the variable, joining and constant region genes of the human T-cell receptor alpha-chain.人类T细胞受体α链可变区、连接区和恒定区基因的组织与序列
Nature. 1985;316(6031):837-40. doi: 10.1038/316837a0.
6
A novel mechanism of somatic rearrangement predicted by a human T-cell antigen receptor beta-chain complementary DNA.一种由人类T细胞抗原受体β链互补DNA预测的体细胞重排新机制。
Science. 1985 Jun 7;228(4704):1204-6. doi: 10.1126/science.3839095.
7
Mouse T cell antigen receptor: structure and organization of constant and joining gene segments encoding the beta polypeptide.小鼠T细胞抗原受体:编码β多肽的恒定区和连接区基因片段的结构与组织
Cell. 1984 Jul;37(3):1101-10. doi: 10.1016/0092-8674(84)90444-6.
8
Genomic organization of the genes encoding mouse T-cell receptor alpha-chain.编码小鼠T细胞受体α链的基因的基因组组织
Nature. 1985;316(6031):832-6. doi: 10.1038/316832a0.
9
Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells.同种异体反应性细胞毒性T细胞和抗原加I-A特异性辅助性T细胞中使用相同的VβT细胞受体基因。
Nature. 1985;315(6018):425-7. doi: 10.1038/315425a0.
10
Abnormal recombination products result from aberrant DNA rearrangement of the human T-cell antigen receptor beta-chain gene.异常重组产物源于人类T细胞抗原受体β链基因的异常DNA重排。
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4890-4. doi: 10.1073/pnas.83.13.4890.

引用本文的文献

1
Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada.淋巴细胞变异型高嗜酸性粒细胞综合征:来自加拿大一家三级转诊中心的病例系列
EJHaem. 2025 Mar 29;6(2):e1109. doi: 10.1002/jha2.1109. eCollection 2025 Apr.
2
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.回复:T细胞淋巴瘤中TRBC1和TRBC2的寡克隆性作为对TRBC导向的嵌合抗原受体T细胞疗法原发性耐药的机制
Nat Commun. 2025 Jan 29;16(1):1103. doi: 10.1038/s41467-025-56396-7.
3
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?
用于治疗T细胞恶性肿瘤的嵌合抗原受体T细胞疗法:细胞免疫疗法是实现治愈的最佳希望吗?
Blood Adv. 2025 Feb 25;9(4):913-923. doi: 10.1182/bloodadvances.2023012263.
4
Advances in CAR-T-cell therapy in T-cell malignancies.嵌合抗原受体 T 细胞疗法在 T 细胞恶性肿瘤中的进展。
J Hematol Oncol. 2024 Jun 24;17(1):49. doi: 10.1186/s13045-024-01568-z.
5
Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia.嵌合抗原受体 T 细胞疗法治疗 T 细胞急性淋巴细胞白血病。
Haematologica. 2024 Jun 1;109(6):1677-1688. doi: 10.3324/haematol.2023.283848.
6
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.靶向 TRBC1 的抗体药物偶联物用于治疗 T 细胞癌症。
Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27.
7
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.靶向 T 细胞恶性肿瘤中 TRBC1 和 TRBC2 的基于结构的免疫疗法工程改造。
Nat Commun. 2024 Feb 21;15(1):1583. doi: 10.1038/s41467-024-45854-3.
8
Differentiation Trajectory of Limbal Stem and Progenitor Cells under Normal Homeostasis and upon Corneal Wounding.角膜缘干细胞和祖细胞在正常稳态和角膜创伤下的分化轨迹。
Cells. 2022 Jun 21;11(13):1983. doi: 10.3390/cells11131983.
9
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells.一种具有细胞内药物释放特性的抗体药物偶联物,对 CD7 阳性细胞具有特异性细胞毒性。
Leuk Res. 2021 Sep;108:106626. doi: 10.1016/j.leukres.2021.106626. Epub 2021 May 18.
10
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies.TRBC1+ T 细胞耗竭可增强抗 TRBC1 CAR-T 治疗 T 细胞恶性肿瘤的疗效。
Mol Cancer. 2020 Nov 21;19(1):162. doi: 10.1186/s12943-020-01282-7.